Immunotherapy Treatment Shows Promise for Resectable Liver Cancer
Perioperative immunotherapy appears to be safe in the setting of resectable hepatocellular carcinoma, according to findings from an open-label phase 2 clinical trial.
Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Perioperative immunotherapy appears to be safe in the setting of resectable hepatocellular carcinoma, according to findings from an open-label phase 2 clinical trial.
Complex surgery is much more likely for advanced ovarian cancer in women with mesenchymal tumors and complex preoperative CT findings.
Although circulating tumor DNA (ctDNA) tests are already marketed for this use, they provide no advantage over standard approaches, concludes a new review.
Long-term results from the Dutch PREOPANC trial confirm that neoadjuvant chemoradiotherapy conveys a survival advantage to patients with resectable and borderline resectable pancreatic cancer.
Data from nearly 100,000 US patients with small, differentiated thyroid cancers showed surgery produced significantly better overall survival compared with surveillance without immediate surgery.